(MFC) Manulife Financial - Ratings and Ratios
Insurance, Annuity, Investment, Banking, Reinsurance
MFC EPS (Earnings per Share)
MFC Revenue
Description: MFC Manulife Financial
Manulife Financial Corp (MFC) is a diversified financial services company operating globally, with a presence in the US, Canada, Asia, and other international markets. The companys business is segmented into Wealth and Asset Management, Insurance and Annuity Products, and Corporate and Other, offering a range of financial products and services to various client segments.
The companys Wealth and Asset Management segment provides investment advice and solutions to retirement, retail, and institutional clients, leveraging multiple distribution channels. Meanwhile, the Insurance and Annuity Products segment offers a variety of insurance and annuity products, including individual life insurance, long-term care insurance, and guaranteed annuity products, through various distribution channels. MFC also engages in other businesses, such as property and casualty reinsurance, timberland and agricultural portfolio management, and integrated banking products and services.
From a performance perspective, key metrics to consider include the companys Return on Equity (RoE) of 10.42%, indicating a moderate level of profitability. The Price-to-Earnings (P/E) ratio of 16.21 and Forward P/E of 10.47 suggest that the stock may be reasonably valued relative to its earnings. Additionally, the companys Market Capitalization of CAD 73.1 billion indicates a significant market presence. Other relevant KPIs to monitor include the companys Asset Under Management (AUM), premium revenue growth, and dividend yield, which can provide insights into its financial health and growth prospects.
To further evaluate MFCs investment potential, it is essential to analyze its financial statements, assess its competitive positioning within the life and health insurance industry, and monitor industry trends. Key drivers to watch include changes in interest rates, regulatory developments, and shifts in consumer behavior, which can impact the companys business segments and overall performance.
Additional Sources for MFC Stock
MFC Stock Overview
Market Cap in USD | 53,324m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception |
MFC Stock Ratings
Growth Rating | 84.9 |
Fundamental | 28.8 |
Dividend Rating | 57.2 |
Rel. Strength | -0.74 |
Analysts | - |
Fair Price Momentum | 44.60 CAD |
Fair Price DCF | 189.71 CAD |
MFC Dividends
Dividend Yield 12m | 2.83% |
Yield on Cost 5y | 7.61% |
Annual Growth 5y | 1.04% |
Payout Consistency | 72.7% |
Payout Ratio | 30.5% |
MFC Growth Ratios
Growth Correlation 3m | -2.3% |
Growth Correlation 12m | 51.4% |
Growth Correlation 5y | 90.1% |
CAGR 5y | 21.93% |
CAGR/Max DD 5y | 1.02 |
Sharpe Ratio 12m | 1.02 |
Alpha | 9.83 |
Beta | 0.800 |
Volatility | 18.06% |
Current Volume | 3450.7k |
Average Volume 20d | 4405.2k |
Stop Loss | 41.2 (-3%) |
As of July 19, 2025, the stock is trading at CAD 42.48 with a total of 3,450,730 shares traded.
Over the past week, the price has changed by +1.17%, over one month by +0.85%, over three months by +7.92% and over the past year by +20.73%.
Neither. Based on ValueRay´s Fundamental Analyses, Manulife Financial is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.77 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MFC is around 44.60 CAD . This means that MFC is currently overvalued and has a potential downside of 4.99%.
Manulife Financial has no consensus analysts rating.
According to our own proprietary Forecast Model, MFC Manulife Financial will be worth about 51.3 in July 2026. The stock is currently trading at 42.48. This means that the stock has a potential upside of +20.72%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 47.8 | 12.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 51.3 | 20.7% |